IVC filter recalled | Growing interest in endovascular procedures | FDA clears new robotic system | PE thrombectomy on the rise

Customers are urged to stop using these devices right away.

Sahil Parikh, MD, said it was clear at TCT 2025 that the specialty is getting more and more involved with endovascular procedures for stroke, pulmonary embolism and peripheral artery disease.

The recall was put in place after a hydrophilic coating was discovered on the inside of the devices. According to the FDA, patients treated with the catheters could face a number of significant risks. 

GenesisX represents the company’s most accessible robotic system to date. It requires no room shielding or structural anchoring, for example, and the size has been significantly reduced.

Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT).

There is a risk of certain pericardial patches not being as strong or durable as needed. Customers are urged to identify, quarantine and replace these devices.

The new findings, presented during a late-breaking presentation, focused on 110 PAD patients treated with Shockwave Medical's Javelin Peripheral IVL Catheter.

Tulyp Medical, a French medtech startup, has emerged from stealth focused on securing FDA clearance for a patented perfusion device.

Siemens Healthineers and Styker are collaborating on a brand new robotic system that can perform a variety of neurovascular procedures.